Maki Tanioka - Concepedia

Author

Maki Tanioka

Hyogo Prefectural Cancer Center ORCID

Also Known As

Fan, Cheng, M Tanioka, M. Tanioka, M., Tanioka, Maki Tanioka, Mesri, Mehdi, Minako Tanioka, Tanioka, Maki

176

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hyogo Prefectural Cancer Center Tokyo National Hospital National Cancer Center Hospital East Kyoto University University of North Carolina at Chapel Hill

About

Maki Tanioka is an author at Hyogo Prefectural Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	497
2	Health Sciences	1	1	10
3	Public Health	1	1	18
4	Cell Biology	1	1	21
5	Epidemiology	1	1	51

Maki Tanioka

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts Kuan‐lin Huang, Shunqiang Li, Philipp Mertins, Nature Communications	2017	153
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Maki Tanioka, Joel S. Parker, Katherine A. Hoadley, Clinical Cancer Research	2018	87
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors Maki Tanioka, Hiroshi Nokihara, Noboru Yamamoto, Cancer Chemotherapy and Pharmacology OncologyMedicineOligonucleotidePathologyMolecular Biology	2010	82
Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study Shoji Nagao, Shin Nishio, Hirofumi Michimae, Gynecologic Oncology Sgsg-012/gotic-004/intergroup StudyMedicineCancer ManagementGynecologyEndometrial Cancer	2013	75
A Phase I, dose‐finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,† Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada, Cancer Science Breast OncologyCancer ManagementPharmacokinetic StudyPathologyPharmacotherapy	2011	75
A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy Maki Tanioka, Akihito Kitao, Koji Matsumoto, British Journal of Cancer	2013	64
Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy Maki Tanioka, Carlos Shimizu, Kan Yonemori, British Journal of Cancer	2010	53
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches Arran Turnbull, Çiğdem Selli, Carlos Martínez-Pérez, BMC Bioinformatics	2020	53
Risk of hepatocellular carcinoma in patients with cirrhosis in Japan Masaru Kato, Manabu Nakata, M. D. Shigenobu Nagataki, EpidemiologyHepatologyMedicineLiver PhysiologyPathology	1994	51
Establishment of the acute myeloid leukemia cell line Kasumi‐6 from a patient with a dominant‐negative mutation in the DNA‐binding region of the <i>C/EBPα</i> gene Hiroya Asou, Adrian F. Gombart, Seisho Takeuchi, Genes Chromosomes and Cancer	2002	35

Page 1